Pharmacological Effects of "Jutsu" (Atractylodis rhizome and Atractylodis lanceae rhizome) on 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-Induced Head Twitch Response in Mice (I)

被引:13
作者
Murayama, Chiaki [1 ]
Wang, Ching-Chiung [2 ]
Michihara, Seiwa [1 ]
Norimoto, Hisayoshi [1 ]
机构
[1] Kracie Pharma Ltd, Kampo Res Labs, Takaoka, Toyama 9330856, Japan
[2] Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei 110, Taiwan
关键词
hallucinations; Atractylodis rhizome (Byaku-jutsu); Atractylodis lanceae rhizome (So-jutsu); atractylenolide III; beta-eudesmol; DOI-induced head-twitch; HALLUCINATIONS; YOKUKANSAN; RECEPTORS;
D O I
10.3390/molecules190914979
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Hallucinations are a common non-motor symptom of Parkinson's disease and various forms of dementias. Yokukansan and Yokukansankachimpihange have attracted attention due to their effectiveness in the treatment of hallucinations of dementia. To clarify which component in these formulas contribute to the effects, at first, we focused on their differences in compositions to examine the pharmacological effects on the selective 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head-twitch response (HTR) in mice that has been used as animal hallucination model. Results indicated that water extract of Byaku-jutsu (Atractylodes japonica) showed a stronger inhibitory effect on DOI-induced HTR than that of So-jutsu (A. lancea) corresponding to their major constituents of atractylenolide III and beta-eudesmol, and suggested that the major constituents should be active constituents contributing to the antihallucination effects of Byaku- and So-jutsu. Besides, the part B-C ring (butenolide) in atractylenolide III was found to be similar to the structure of serotonin and suggested that the B-C ring may partially play role in antagonistic activity against serotonin receptors. Thus, a novel, rational design of butenolide-related compounds may as potential lead compounds for new drug development. Analysis of the chemical components of Byaku- and So-jutsu and further study on their structure-activity relationships are currently in progress.
引用
收藏
页码:14979 / 14986
页数:8
相关论文
共 18 条
[1]
A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[2]
Bertram G.K., 2004, DRUGS ABUSE BASIC CL, P523
[3]
A POSSIBLE CORRELATION BETWEEN DRUG-INDUCED HALLUCINATIONS IN MAN AND A BEHAVIOURAL RESPONSE IN MICE [J].
CORNE, SJ ;
PICKERIN.W .
PSYCHOPHARMACOLOGIA, 1967, 11 (01) :65-65
[4]
Differential ontogenesis of three DOI-induced behaviors in mice [J].
Darmani, NA ;
Shaddy, J ;
Gerdes, CF .
PHYSIOLOGY & BEHAVIOR, 1996, 60 (06) :1495-1500
[5]
Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex [J].
Egashira, Nobuaki ;
Iwasaki, Katsunori ;
Ishibashi, Ayumi ;
Hayakawa, Kazuhide ;
Okuno, Ryoko ;
Abe, Moe ;
Uchida, Naoki ;
Mishima, Kenichi ;
Takasaki, Kotaro ;
Nishimura, Ryoji ;
Oishi, Ryozo ;
Fujiwara, Michihiro .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (06) :1516-1520
[6]
Feng X., 2009, CHINESE PHARMACOL B, V25, P951
[7]
HIKINO H, 1964, CHEM PHARM BULL, V12, P755
[8]
Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine [J].
Iwasaki, Koh ;
Kosaka, Kenji ;
Mori, Hideo ;
Okitsu, Reina ;
Furukawa, Katsutoshi ;
Manabe, Yuta ;
Yoshita, Mitsuhiro ;
Kanamori, Aya ;
Ito, Nobuo ;
Wada, Kenji ;
Kitayama, Michio ;
Horiguchi, Jun ;
Yamaguchi, Shuhei ;
Takayama, Shin ;
Fukuhara, Ryuji ;
Ouma, Shinji ;
Nakano, Seigo ;
Hashimoto, Mamoru ;
Kinoshita, Toru .
PSYCHOGERIATRICS, 2012, 12 (04) :235-241
[9]
Japanese Pharmacopoeia Editorial Committee, 2006, JAP PHARM, P1604
[10]
Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia [J].
Kawanabe, Tadaaki ;
Yoritaka, Asako ;
Shimura, Hideki ;
Oizumi, Hideki ;
Tanaka, Shigeki ;
Hattori, Nobutaka .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (02) :284-287